School of Medicine
Showing 1-41 of 41 Results
-
Blake K. Scanlon, Ph.D.
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioThe overarching aim of Dr. Scanlon’s research is to develop and evaluate low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. To that end, the Caregiver Technology Division of the Scanlon Lab aims to enhance patient- and family-centered care through novel, broadly customizable, and highly scalable caregiver interventions. In parallel, the Neurodegenerative Division of the Scanlon Lab focuses on the development and application of cognitive, neuropsychiatric, and biological markers for the initiation and progression of neurodegeneration.
Dr. Scanlon received his bachelor’s degree in Neuroscience and doctorate in Clinical Health Psychology from the University of Miami. After concluding his clinical internship in Geropsychology/Neuropsychology at the VA Palo Alto Health Care System (VAPAHCS), he completed fellowships in Aging and Dementia at Stanford University School of Medicine and VAPAHCS. Dr. Scanlon is currently a VA Career Development Awardee in the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) and Stanford/VA Aging Clinical Research Center where his work focuses on developing and evaluating low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. He also serves as Co-Director of the Stanford/VA California Alzheimer's Disease Center, Chair of the VAPAHCS Dementia Committee, and Co-Chair of the Department of Veterans Affairs VISN 21 Dementia Committee. -
Logan Schneider
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesCurrent Research and Scholarly InterestsFrom a research perspective, my long-term career plan is to refine the understanding of normal and dysfunctional sleep, much like the Epilepsy Phenome/Genome Project (EPGP) and Epi4K are doing for the enigmatic epilepsies. Insufficient sleep has been deemed a public health problem with poorly understood behavioral and physiologic sleep disorders lying at the core of the issue. I am currently using well-defined distinct and objective phenotypes (e.g. periodic limb movements, hypocretin-deficient narcolepsy) to acquire the analytic skills necessary to expand my knowledge of both signal processing and genetics, with the former enhancing my ability to identify and/or refine sleep phenotypes, and the latter facilitating the pathophysiological understanding of these phenotypes. As a consequence of a better link between symptoms/phenotypes, physiology, and genetic risks, more personally targeted and effective therapeutics can be developed to address the enriched spectrum of sleep disorders.
-
Ahmed Shamma
Assistant Clinical Research Coordinator, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordACRC in the Brain Stimulation Lab at Stanford University Medical Center
-
Dave Singh
Adjunct Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr Dave Singh is an Adjunct Professor in Sleep Medicine, where he is developing a Virtual Craniofacial Laboratory. He is a Board Member of the American Sleep and Breathing Association, Member of the World Sleep Society, Academic Fellow of the World Federation of Orthodontists, and Fellow of the International Association for Orthodontics, where he was awarded prizes in 2005, 2013 and 2014. He has published over 200 articles in the peer-reviewed medical, dental and orthodontic literature, and has published 9 books/chapters. Dr. Singh was the 2019 recipient of the US Invisible Disabilities Association award for ‘providing the possibility of healthy lives for millions living with illness, pain and disability’. In 2020, Dr Singh was given a lifetime achievement award for his work on sleep apnea ‘exemplifying leadership, excellence, and entrepreneurship in service to humanity and the advancement of global health’. Currently, he is Founder and Chief Medical Officer, Vivos Therapeutics, Inc.
-
David Smith, M.D.
Adjunct Professor, Psych/General Psychiatry and Psychology (Adult)
BioDr. Smith is a psychiatrist and clinical psychopharmacologist in private practice in Palo Alto, CA, and an Adjunct Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He majored in both biological science and English literature at Cornell University, received his M.D. from UCLA, and completed his psychiatry residency and NIMH research fellowship at Stanford University School of Medicine and Hospital.
-
Ana Lilia Soto
Youth Development Manager, Psych/Public Mental Health & Population Sciences
Current Role at StanfordYouth Development Manager
-
Caleb Matthew Spiro
Temp CRCA, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioMy main research interest revolves around understanding the general cognitive and affective properties of the mind, and how the prognosis of good and poor mental health status affects the developmental trajectories under chronic stress. To what extent reward-based networks can lead to increased proximity to vulnerability or heightened sensitivity to mental illness, specifically within the context of youth and adolescents, is an area that I am especially interested in. I am most interested in what factors help individuals become more resilient and build a narrative that they can get better with the right treatment practices. I believe that this can be done by combining neuroscience and functional imaging techniques (ex: fMRI, EEG) into the study and practice of clinical psychology.
